Endocrine Drugs
154 FDA-approved drugs
TheraRadar tracks 154 FDA-approved endocrine drugs from 88 companies across 14 drug classes, led by Novartis, with 48 active clinical trials in the pipeline. Explore recent approvals, top companies, active trials by indication, and drug classes for Endocrine.
Endocrine Approvals by Year
1
'15
'16
1
'17
2
'18
1
'19
5
'20
3
'21
3
'22
1
'23
3
'24
2
'25
'26
Recent Endocrine Drug Approvals
PALSONIFY
PALTUSOTINE HYDROCHLORIDE
adults with acromegaly who had an inadequate response to surgery and/or for whom surgery is not an o...
2025-09-25
CRINETICS
SSTR2
KHINDIVI
HYDROCORTISONE
KHINDIVI is indicated as replacement therapy in pediatric patients 5 years of age and older with adr...
2025-05-28
ETON
Glucocorticoid receptor
CRENESSITY
CRINECERFONT
CRENESSITY is indicated as adjunctive treatment to glucocorticoid replacement to control androgens i...
2024-12-13
NEUROCRINE
CRF1R
BYNFEZIA PEN
OCTREOTIDE ACETATE
treat ment of severe diarrhea and flushing episodes associated with metastatic carcinoid tumors...
2024-09-27
Sun Pharma
Somatostatin receptor
YORVIPATH
PALOPEGTERIPARATIDE
hypoparathyroidism in adults...
2024-08-09
ASCENDIS PHARMA BONE
PTH1R
NGENLA
SOMATROGON-GHLA
pediatric patients aged 3 years and older who have growth failure due to an inadequate secretion of ...
2023-06-27
Pfizer
GH receptor
KYZATREX
TESTOSTERONE UNDECANOATE
testosterone replacement therapy in adult males for conditions associated with a deficiency or absen...
2022-07-27
MARIUS
AZMIRO
TESTOSTERONE CYPIONATE
testosterone replacement therapy in males in conditions associated with a deficiency or absence of e...
2022-06-02
AZURITY
TLANDO
TESTOSTERONE UNDECANOATE
testosterone replacement therapy in adult males for conditions associated with a deficiency or absen...
2022-03-28
VERITY
RECORLEV
LEVOKETOCONAZOLE
endogenous hypercortisolemia in adult patients with Cushing’s syndrome for whom surgery is not an op...
2021-12-30
STRONGBRIDGE
LANREOTIDE ACETATE
LANREOTIDE ACETATE
adult patients with unresectable, well or moderately differentiated, locally advanced or metastatic ...
2021-12-17
AMNEAL
Somatostatin
SKYTROFA
LONAPEGSOMATROPIN-TCGD
the: Treatment of pediatric patients 1 year and older who weigh at least 11...
2021-08-25
ASCENDIS PHARMA ENCOCRINOLOGY DIV A/S
Growth hormone receptor
ALKINDI SPRINKLE
HYDROCORTISONE
ALKINDI SPRINKLE is indicated as replacement therapy in pediatric patients with adrenocortical insuf...
2020-09-29
ETON
Glucocorticoid receptor
SOGROYA
SOMAPACITAN-BECO
the: • Treatment of pediatric patients aged 2...
2020-08-28
Novo Nordisk
GH receptor
METYROSINE
METYROSINE
INDICATIONS AND USAGE Metyrosine capsules are indicated in the treatment of patients with pheochromo...
2020-07-24
LEADING
MYCAPSSA
OCTREOTIDE ACETATE
long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment...
2020-06-26
CHIESI
Somatostatin receptor
ISTURISA
OSILODROSTAT PHOSPHATE
endogenous hypercortisolemia in adults with Cushing's syndrome for whom surgery is not an option or ...
2020-03-06
RECORDATI RARE
CYP11B1
JATENZO
TESTOSTERONE UNDECANOATE
testosterone replacement therapy in adult males for conditions associated with a deficiency or absen...
2019-03-27
TOLMAR
XYOSTED (AUTOINJECTOR)
TESTOSTERONE ENANTHATE
testosterone replacement therapy in adult males for conditions associated with a deficiency or absen...
2018-09-28
ANTARES PHARMA INC
CINACALCET HYDROCHLORIDE
CINACALCET HYDROCHLORIDE
secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on dialysis ...
2018-03-08
STRIDES PHARMA
Showing the 20 most recent of 154 endocrine drugs. View all 154 →
Top Endocrine Companies
Endocrine Active Trials by Indication
48 active trials — the forward pipeline, not just approvals.
Growth Hormone Deficiency 15 Hyperthyroidism 13 Hypothyroidism 9 Acromegaly 6 Adrenal Insufficiency 5
All competitive landscapes → Endocrine Drug Classes
Androgen 5
Recombinant Human Growth Hormone 3
Corticosteroid 2
Catecholamine Synthesis Inhibitor 2
Somatostatin Analog 2
Thyroid Hormone Synthesis Inhibitor 2
Adrenocorticotropic Hormone 2
Corticotropin-releasing Factor Type 1 Receptor Antagonist 1
Cortisol Synthesis Inhibitor 1
Parathyroid Hormone 1
Endocrine at a Glance
- Total Drugs
- 154
- Companies
- 88
- Drug Classes
- 14
- Active Trials
- 48
- Latest Approval
- 2025-09-25